is compounded semaglutide safe for weight loss FDA Warns on Certain Forms of Semaglutide for weight loss |

Glucagon-like peptide-1 (GLP-1) receptor agonists have become one of the most researched weight loss medications, with clinical trials showing average reductions of 1522% body weight over 68 weeks

Open communication with your doctor is key to finding a solution that works for you and your blood sugar management

Kidney and heart failure outcomes associated with SGLT2 inhibitor use

At TrMD, GLP-1 therapy is approached with a focus on: The goal is not simply weight loss, but optimization of overall health, metabolic function, and longevity through a comprehensive, integrative approach .

Retatrutide shows slightly higher potential (~ 24 %), but the difference is small compared to waiting years for treatment